Search Results
226 items found for "Chronic obstructive pulmonary disease (COPD)"
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases
- GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
protein-coupled receptor (GPCR) kinases (GRKs) are associated with the pathophysiology of Alzheimer's disease
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled receptors) in disease-relevant
- 📰 GPCR Weekly News, March 4 to 10, 2024
modulator VU0486846 reduces neurogliosis in female Alzheimer's mice The association of GNB5 with Alzheimer disease of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer's disease
- New role of β-arrestins in MOR signaling
Morphine is one of the most widely used and proven analgesic for the treatment of severe acute or chronic Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome.
- 📰 GPCR Weekly News, October 16 to 22, 2023
sites of GPCRs for drug discovery Targeting mGluR group III for the treatment of neurodegenerative diseases Methods & Updates in GPCR Research Advancements in the use of xenopus oocytes for modelling neurological disease
- N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling
Neisseria meningitidis is a Gram-negative opportunistic pathogen that is responsible for causing human diseases
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCRs in Cardiology, Endocrinology, and Taste Gender Differences in GRK2 in Cardiovascular Diseases and Manager Director of Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of hereditary degenerative diseases affecting 1 of 4000 people worldwide
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Sir William Osler Scientists have long sought to discover a “golden bullet” that would cure every disease The more we know about the pathology of diseases, the more complicated it is to modulate them by a specific The choice of pathway can result in different cellular responses, underscoring the criticality of precise
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
numerous GPCRs have been studied for their impact on pathologic conditions, including cardiovascular diseases
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Neuroscience Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
(GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
effects of CB2 receptor activation, make this receptor an intriguing target for treating schizophrenia, a disease
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
phases of clinical development, and across multiple therapeutic areas, including Oncology, Infectious Diseases
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
with the fact that dysregulation of compartmentalized GPCR signaling has been implicated in various diseases aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative diseases Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases
- VAMP2: a crucial player in the delivery of MOR to the synapse
dysfunction in the MOR-SNARE complex interaction can lead to various neurological disorders, such as chronic Struct. Mol. Biol. 15:658–664.
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
receptor type 9 (CCR9) antagonist and previous phase III clinical candidate for the treatment of Crohn's disease
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
protein-coupled receptors (aGPCRs) are keys of many physiological events and attractive targets for various diseases
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
The mGlu5 receptor is a promising target for the treatment of psychiatric and neurodegenerative diseases
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
While these small protein GPCRs are valuable drug targets linked to serious diseases, many remain undrugged antagonist analogs have demonstrated powerful efficacies across a range of animal models spanning different disease Since many inflammatory diseases are driven by inappropriate recruitment of monocytes into tissues, CCR2 diversified portfolio of GPCR-targeted drug candidates for the treatment of cancer and other serious diseases Journal of Infectious Diseases, 199, 1525-1527. https://doi.org/10.1086/598685 · Demonstration
- 📰 GPCR Weekly News, November 20 to 26, 2023
Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases concept to metabolomics: New insights into pregnenolone function Molecular characterization of lumpy skin disease
- 📰 GPCR Weekly News, June 19 to 25, 2023
Please note that you will have to submit a 1-minute abstract video. Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases.
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
September 2022 "G-protein-coupled receptors (GPCRs) are involved in a wide array of physiological and disease
- 📰 GPCR Weekly News, October 2 to 8, 2023
GPCR Function Interplay of Cholesterol and Actin in Neurotransmitter GPCR Signaling: Insights from Chronic